by Raynovich Rod | Jul 14, 2014 | Biopharmaceuticals
Healthcare Stocks trail other sectors up 0.34%, Energy up 0.8%, Financials up 0.73% and Technology up 0.77% But biotech ETFs are in the Green Biotechnology stocks were mixed today with the following winners among our large cap picks: Gilead Sciences (GILD) up...
by Raynovich Rod | Jul 3, 2014 | Biopharmaceuticals
Rayno Diagnostics and Tools-Sequencing Rules Diagnostics and Tools stocks tracked biotech stocks during the huge moves in January/February and sold off until the April bottom. However stocks that are more revenue and earnings driven -Cardiovascular Systems(CSII) and...
by Raynovich Rod | Jun 26, 2014 | Biopharmaceuticals, Clinical Diagnostics and Tools
Challenges Ahead But Sequencing Is A Driver We first reported on Personalized Medicine in 2010 with an article on the importance of Biomarkers for exploiting breakthroughs in the molecular basis of disease. The BIO 2014 Personalized Medicine and Diagnostics Forum...
by Raynovich Rod | Jun 11, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Rally Retraces Correction Up To Mid-Point YTD Up until this week we have focused on large cap biopharmaceuticals because of revenue momentum, fair valuations and earnings. A risk -off sentiment due to lack of ASCO buzz and the Q1 speculative bubble downdraft has...
by Raynovich Rod | May 7, 2014 | 2024 Rayno Tools and Diagnostics Portfolio, Biopharmaceuticals
Risk-Off -Stay With Large Caps In case you missed it the speculative frenzy in biotech stocks is over for now but there are always trading opportunities for the short and long term. We recently posted our Q1 Rayno Life Science update for biopharmaceuticals and the...
by Raynovich Rod | Apr 21, 2014 | 2024 Rayno Biopharmaceuticals Portfolio
Biotech Stocks Have A Strong Day-April 15 Bottom Holding Rayno Life Science Portfolios Stick with larger caps through earnings: ABBV, AMGN, ALKS, BIIB, GILD. MOMO mid cap stocks coming back today: INCY MDVN PBYI plus many others. Losers- Cepheid (CPHD and...
by Raynovich Rod | Mar 13, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Clinical Diagnostics and Tools, Life Science ETF's and Mutual Funds
March 17 Update -GREEN DAY with Geopolitical risk on back burner As of 11.38a EDT Industrials lead up 1%, healthcare up 0.8%, IBB up 1.33% Biopharmaceuticals stocks were strong with Rayno large cap picks: Alexion (ALXN $117) up 1.45%, Amgen (AMGN $125) up 1.9%,...
by Raynovich Rod | Mar 4, 2014 | Biopharmaceuticals
Stealth Biotech Sell-Off-Caution Urged-Red Screen Aegerion (AEGR $50) down 7%, Medivation (MDVN $66.9) off 5%, Puma (PBYI $113.5) off 5.4%, IBB ($261.75) off 2.8% , XBI ($161.9 off 3% etc. ———-from 5/4——– Most Biotech Stocks...
by Raynovich Rod | Feb 27, 2014 | 2024 Rayno Biopharmaceuticals Portfolio, Clinical Diagnostics and Tools
Rayno Life Science Movers -Diagnostics Review Next Week Despite some choppiness in biotech trading this week many of our stocks did well. I won’t go into some of the unusual volatility in other small and mid-caps lately but that is part of the reason for my...
by Raynovich Rod | Feb 3, 2014 | 2024 Rayno Tools and Diagnostics Portfolio
Molecular Diagnostics and Sequencing Technologies Are Big Winners in January 2014 But Recent Two Day Sell-Off Has Done Damage To Many Stocks Diagnostic stocks were a sea of red today after a huge January driven by growth expectations from new products and platform...